Monique K. Wasunna
Nairobi, Kenya
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 31 publications
Inspiring, shaping and sustaining an African research & development agenda.
Journal: Nature medicine
Published: June 24, 2026
Disease-Specific Differences in Pharmacokinetics of Paromomycin and Miltefosine Between Post-Kala-Azar Dermal Leishmaniasis and Visceral Leishmaniasis Patients in Eastern Africa.
Journal: The Journal of infectious diseases
Published: May 09, 2024
Population pharmacokinetics of a combination of miltefosine and paromomycin in Eastern African children and adults with visceral leishmaniasis.
Journal: The Journal of antimicrobial chemotherapy
Published: May 12, 2023
Leishmania blood parasite dynamics during and after treatment of visceral leishmaniasis in Eastern Africa: A pharmacokinetic-pharmacodynamic model.
Journal: PLoS neglected tropical diseases
Published: May 09, 2023
Safety and efficacy of paromomycin/miltefosine/liposomal amphotericin B combinations for the treatment of post-kala-azar dermal leishmaniasis in Sudan: A phase II, open label, randomized, parallel arm study.
Journal: PLoS neglected tropical diseases
Published: April 26, 2023
Paromomycin and Miltefosine Combination as an Alternative to Treat Patients With Visceral Leishmaniasis in Eastern Africa: A Randomized, Controlled, Multicountry Trial.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: May 04, 2022
Geographical Variability in Paromomycin Pharmacokinetics Does Not Explain Efficacy Differences between Eastern African and Indian Visceral Leishmaniasis Patients.
Journal: Clinical pharmacokinetics
Published: May 04, 2021
Blood Parasite Load as an Early Marker to Predict Treatment Response in Visceral Leishmaniasis in Eastern Africa.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: November 09, 2020
Low antileishmanial drug exposure in HIV-positive visceral leishmaniasis patients on antiretrovirals: an Ethiopian cohort study.
Journal: The Journal of antimicrobial chemotherapy
Published: August 28, 2020
Inclusion of women susceptible to and becoming pregnant in preregistration clinical trials in low- and middle-income countries: A proposal for neglected tropical diseases.
Journal: PLoS neglected tropical diseases
Published: June 12, 2020
Characterizing the non-linear pharmacokinetics of miltefosine in paediatric visceral leishmaniasis patients from Eastern Africa.
Journal: The Journal of antimicrobial chemotherapy
Published: September 25, 2019
Development of a Multiplexed Assay for Detection of Leishmania donovani and Leishmania infantum Protein Biomarkers in Urine Samples of Patients with Visceral Leishmaniasis.
Journal: Journal of clinical microbiology
Published: January 16, 2019
Last Updated: 09/26/2026